Literature DB >> 8892064

Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

T Esmonde1, E Giles, M Gibson, J R Hodges.   

Abstract

To investigate the relationship between disease severity, cognitive impairment and depression in progressive supranuclear palsy (PSP) we studied a group of 25 patients who fulfilled strict research criteria and 25 matched controls. Disease severity was judged from the duration of symptoms, level of physical disability using the Columbia Rating Scale (CRS), and the degree of eye movement abnormality. The neuropsychological battery was designed to assess attention and executive function, visual and auditory perception, semantic memory and language production. Although the PSP group were significantly impaired on almost all of these measures, the most profound deficits were on tests of sustained and divided attention. There was no correlation between cognitive impairment and either disease duration or scores on the CRS, but performance on tests of attention correlated significantly with the degree of ocular motor impairment. Depression was found to be common in PSP but did not correlate with any other parameters. It is concluded that the cognitive deficit in PSP is widespread and independent of depression. The association between the severity of eye movement disorder and deficits in sustained and divided attention leads us to postulate that pathology involving the midbrain periaqueductal region may be critical for breakdown in these fundamental processes.

Entities:  

Mesh:

Year:  1996        PMID: 8892064     DOI: 10.1007/bf00878659

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.

Authors:  B Dubois; B Pillon; F Legault; Y Agid; F Lhermitte
Journal:  Arch Neurol       Date:  1988-11

4.  The psychological test pattern in progressive supranuclear palsy.

Authors:  D Kimura; H J Barnett; G Burkhart
Journal:  Neuropsychologia       Date:  1981       Impact factor: 3.139

5.  Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

Authors:  T W Robbins; M James; A M Owen; K W Lange; A J Lees; P N Leigh; C D Marsden; N P Quinn; B A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

6.  Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

Authors:  B Pillon; B Dubois; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

7.  Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  E R Maher; E M Smith; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

8.  [Frontal syndrome of progressive supranuclear palsy].

Authors:  J Cambier; M Masson; F Viader; J Limodin; A Strube
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

9.  Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.

Authors:  B Pillon; B Dubois; A Ploska; Y Agid
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

10.  The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  E R Maher; A J Lees
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

View more
  16 in total

1.  The relationship between clinical and pathological variables in Richardson's syndrome.

Authors:  Emma C Schofield; John R Hodges; Thomas H Bak; John H Xuereb; Glenda M Halliday
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

2.  Cognitive impairment in progressive supranuclear palsy is associated with tau burden.

Authors:  Shunsuke Koga; Adam Parks; Koji Kasanuki; Monica Sanchez-Contreras; Matthew C Baker; Keith A Josephs; J Eric Ahlskog; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; Zbigniew K Wszolek; Rosa Rademakers; Dennis W Dickson
Journal:  Mov Disord       Date:  2017-10-30       Impact factor: 10.338

Review 3.  Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Authors:  Deborah A Hall; Maria João Forjaz; Lawrence I Golbe; Irene Litvan; Christine Ann M Payan; Christopher G Goetz; Albert F G Leentjens; Pablo Martinez-Martin; Anne Pavy-Le Traon; Cristina Sampaio; Bart Post; Glenn Stebbins; Daniel Weintraub; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

Review 4.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

5.  Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Authors:  Leonardo Almeida; Bilal Ahmed; Roger Walz; Sol De Jesus; Addie Patterson; Daniel Martinez-Ramirez; David Vaillancourt; Dawn Bowers; Herbert Ward; Michael S Okun; Nikolaus R McFarland
Journal:  Mov Disord Clin Pract       Date:  2016-06-24

Review 6.  Biomarkers in frontotemporal lobar degenerations--progress and challenges.

Authors:  William T Hu; John Q Trojanowski; Leslie M Shaw
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

Review 7.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

8.  Imaging correlates of depression in progressive supranuclear palsy.

Authors:  Daniele Urso; Benedetta Tafuri; Roberto De Blasi; Salvatore Nigro; Giancarlo Logroscino
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 4.849

9.  Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.

Authors:  Ji-Hyun Choi; Heejung Kim; Jung Hwan Shin; Jee-Young Lee; Han-Joon Kim; Jong-Min Kim; Beomseok Jeon
Journal:  J Neurol       Date:  2020-09-21       Impact factor: 4.849

10.  Visuospatial functions in atypical parkinsonian syndromes.

Authors:  T H Bak; D Caine; V C Hearn; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.